Bicara appoints President Ryan Cohlhepp as CEO effective Jan. 1, while J&J veteran John Reed joins Madrigal board
read at Endpoints ↗Neutral
Bicara Therapeutics announced a leadership transition, naming its current President and COO Ryan Cohlhepp as the new chief executive officer effective Jan. 1.
Cohlhepp will take over the role as the company prepares for the departure of its current CEO later this year.
Separately, John Reed, a senior executive from Johnson & Johnson, has been appointed to the board of Madrigal Pharmaceuticals.
Both moves signal strategic realignments as the companies position themselves for upcoming development initiatives.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Bicara shakes up leadership ahead of CEO departure; J&J's John Reed joins Madrigal's board”
read at Endpoints ↗91 words · retrieved Aug 14
comments(0)
5-min edit window · permanent after that